Azenta Launched Custom PCR Diagnostic Consumables

The company introduced new customization options for PCR plates to support diagnostic kit manufacturers globally.

Updated on Oct. 10, 2026 in Life Sciences

Isometric editorial illustration of a multi-well PCR plate and geometric laboratory components, representing specialized diagnostic manufacturing equipment.
Azenta Life Sciences has launched a new line of customizable PCR plates designed to aid diagnostic kit manufacturers in scaling production for molecular applications. AI Illustration. Upload story photo >

Live Poll

Should medical supply companies prioritize offering customized products over standardized options for diagnostic kit manufacturing?

Azenta Life Sciences announced the availability of custom PCR consumables designed specifically for diagnostic kit manufacturers. The new offerings aim to support scalable production for applications like infectious disease diagnostics.

Why it matters

Manufacturers face increasing pressure to deliver high-quality diagnostic kits that meet stringent regulatory requirements. Standard off-the-shelf components often fail to address the specific needs of specialized molecular applications.

Azenta holds ISO 9001 and ISO 13485 certifications for its manufacturing facilities. The new product line supports infectious disease diagnostics through compatibility with automated reagent dispensing and heat sealing.

The players

Azenta Life Sciences

This life sciences company provides specialized solutions and consumables for the global diagnostics and research sectors.

The details

Clients can specify custom requirements including plate formats, well and frame colors, surface treatments, and specific coatings. The product line also allows for customized barcode or 2D coding to improve sample tracking during high-throughput testing processes.

Timeline

  1. October 9, 2026: The company announced the availability of the custom PCR consumables.

The Big Picture

The adoption of the ISO 13485 medical device quality management standard follows a pattern set by major suppliers to ensure clinical grade consistency in diagnostic components. This development bridges the gap between mass-market laboratory supplies and the highly regulated requirements of clinical diagnostic manufacturing.

For diagnostic manufacturers, these custom options mean a reduction in the need for secondary modifications after purchasing raw components. This streamlined supply chain could lead to faster turnaround times for the production of essential infectious disease test kits.

The takeaway

Customized manufacturing components help firms meet complex diagnostic demands that general supplies cannot satisfy. Manufacturers should evaluate whether specialized surface treatments or coding could improve their own throughput and sample tracking accuracy.

Further reading

For more information on the evolving standards in testing equipment, visit our Life Sciences section.

More information

View the complete product specifications on the Azenta molecular diagnostics kits product page.

Source note: This article includes information reported by Labmate online.

Live Poll

Should medical supply companies prioritize offering customized products over standardized options for diagnostic kit manufacturing?